Clinical Trials Logo

Hemorrhage clinical trials

View clinical trials related to Hemorrhage.

Filter by:

NCT ID: NCT02954068 Completed - Clinical trials for Postpartum Hemorrhage

IV Versus IM Administration of Oxytocin for Postpartum Bleeding

Start date: December 1, 2016
Phase: Phase 4
Study type: Interventional

This double-blind, randomized controlled trial will evaluate the effect of the route of administration of 10 IU of oxytocin on the average blood loss postpartum. Participants will be randomized to receive 10 IU of oxytocin by IV infusion or 10 IU of oxytocin by injection IM

NCT ID: NCT02946931 Completed - Hemorrhage Clinical Trials

All-Case Surveillance of Prizbind®

Start date: November 18, 2016
Phase:
Study type: Observational

To evaluate safety and effectiveness of Prizbind® for Intravenous Solution 2.5 g under Japanese clinical condition.

NCT ID: NCT02946866 Active, not recruiting - Clinical trials for Intracerebral Hemorrhage

CoHOrt of Cerebral CavernOus maLformATion: multicEnter Prospective Observational Study

CHOCOOATE
Start date: June 2016
Phase:
Study type: Observational

The aim of this prospective study is to reveal the natural history of symptomatic hemorrhage in adult patients with cerebral cavernous malformation with the goal of informing the treatment plan.

NCT ID: NCT02946437 Withdrawn - Clinical trials for Subarachnoid Haemorrhage (SAH)

Sevoflurane in Subarachnoidal Haemorrhage

Sevoflurane
Start date: November 1, 2015
Phase: Phase 2
Study type: Interventional

Feasibility and safety of short term application of sevoflurane in patients with SAH treated with aneurysm coiling or clipping in the setting of a neurointensive care unit.

NCT ID: NCT02944851 Completed - Clinical trials for Blood Donors, Traumatic Blood Loss

Comparison of the Accuracy of Non-invasive Hemoglobin Measurement (SpHb) and Vena Cava Inferior Ultrasound

Start date: March 2016
Phase:
Study type: Observational

The aim of this work is determine the more successful noninvasive method by comparison of two noninvasive methods ( IVC ultrasound - noninvasive hemoglobin measurement (SpHb)) that used in the detection of patients with blood loss. The works were completed in 6 months. The study was conducted at the blood donation center and in Emergency department. Vital parameters were measured and recorded before making the voluntary blood donation. Following Masimo brand portable device fingers SpHb value was measured.Then IVC diameter of patients in the supine position were measured using ultrasonography. Then he left to donors return in routine blood donation programme. A unit (500ml) of blood were drawn from each donor. After the blood donation process measured and recorded the vital signs again. SpHb was measured noninvasively from finger again. Following these measurements were recorded again by measuring the diameter of IVC.

NCT ID: NCT02943655 Completed - Clinical trials for Heavy Menstrual Bleeding

Treatment of Heavy and/or Prolonged Menstrual Bleeding Without Organic Cause

Start date: November 1, 2017
Phase: Phase 3
Study type: Interventional

Abnormal uterine bleeding encompasses abnormalities in the regularity, duration of flow, frequency, and/or blood flow volume relative to normal menstruation. Of these menstrual abnormalities, heavy menstrual bleeding (HMB), defined objectively as a blood loss of 80 ml or more per menstrual cycle , which is unrelated to pregnancy or known pelvic or systemic disease.

NCT ID: NCT02942719 Recruiting - Clinical trials for Pregnancy Complications

The Establishment and Application of the New Labor Progress Centered System of Reducing Cesarean Section Rates in China

Start date: January 2016
Phase: N/A
Study type: Observational

1. To describe the average labor curve and establish new labor progression standards. 2. Cesarean section rates: Based on big data, the investigator will introduce the international advanced Robson class method and identify the appropriate level of cesarean section rate for each type population. 3. Establishment of "Chinese maternal-fetal medical collaboration network" and APP to promote natural childbirth.

NCT ID: NCT02939092 Not yet recruiting - Gingival Bleeding Clinical Trials

The Effect of Mouthwash Containing Pomegranate Peel Extract and Chlorhexidine Mouthwash on Bleeding on Brushing

Start date: January 2018
Phase: N/A
Study type: Interventional

To evaluate the clinical effectiveness of mouthwash containing pomegranate peel extract and chlorhexidine mouthwash on bleeding on brushing and counting of streptococcus mutans among a group of Egyptian children with permanent dentition.

NCT ID: NCT02938585 Completed - Clinical trials for Congenital Bleeding Disorder

Efficacy and Safety of Turoctocog Alfa for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Chinese Patients With Haemophilia A

guardian TM 7
Start date: December 12, 2016
Phase: Phase 3
Study type: Interventional

This trial is conducted in China. The aim of this trial is to evaluate the clinical efficacy of turoctocog alfa in treatment of bleeding episodes in Chinese patients with severe haemophilia A (FVIII≤1%).

NCT ID: NCT02936661 Not yet recruiting - Clinical trials for Postpartum Hemorrhage, Cesarean Section

Tranexamic Acid for Preventing Postpartum Hemorrhage After Cesarean Section

Start date: April 2017
Phase: Phase 4
Study type: Interventional

It is a multicenter randomized, double-blind and placebo-controlled trial. Totally 6500 women to delivery by cesarean section will be recruited in this study. In addition to routinely oxytocin, the women in study group will receive TXA 1 g in 2 minutes after they delivered their babies, and those in control group will receive placebo. The incidence of postpartum hemorrhage, the amount of bleeding, as well as the side effects will be observed.